Overview

A Study of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy

Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the efficacy, and safety of HR18034 for postoperative analgesia in subjects undergoing hemorrhoidectomy.
Phase:
Phase 3
Details
Lead Sponsor:
Shanghai Hengrui Pharmaceutical Co., Ltd.
Treatments:
Ropivacaine